Donation

According to the National Institutes of Health, CME or Continuing Medical Education, consists of educational activities which serve to maintain, develop, or increase the knowledge, skills, and professional performance and relationships that a physician uses to provide services for patients, the public, or the profession.  

The IMF and Medscape bring you series of videos for myeloma practitioners to earn such CME credits. These series include:

medscape ask dr. durie updates in myeloma treatments
Ask Dr Durie: 2021 Updates in the Multiple Myeloma Treatment Paradigm

In this CME series, IMF Chairman of the Board Dr. Brian G.M. Durie is joined by leading multiple myeloma practitioners to discuss frontline therapy, approaches to relapse care management, novel strategies for heavily pretreated myeloma patients, side effect management, clinical trials, and more. Complete all sections of these activities to earn CME credit.

a
Image Left
White
Oncology Nursing Society meets for it's 45th symposium
New Strategies for Multiple Myeloma Care: Case Studies for Nurses

Multiple myeloma care is rapidly evolving with new agents and combinations, new testing, and risk-adapted treatment strategies. Four highly experienced nurses will share their expertise during this 1.5 CNE symposium (3 sessions of 0.5 CNE) while using real-life patient case scenarios to focus on symptom management, infection control, and nursing implications.

a
Image Left
White
master class on proteasome inhibitors in myeloma therapies
Proteasome Inhibitor-Based Therapy

Presented by Rafat Abonour, MD; Thomas Martin, MD; Joseph Mikhael, MD, MEd, FRCPC; these courses discuss the Role of Proteasome Inhibition in Multiple Myeloma.

a
Image Left
White
continuous myeloma treatment doctor education
Continuous Treatment in Multiple Myeloma

Presented by Medscape Oncology and moderated by Dr. Brian G.M. Durie the sections of this activity include: Continuous Treatment of Transplant-Ineligible Patients, After Transplant: The Role of Maintenance With or Without Prior Consolidation, Selecting Myeloma Maintenance Therapy for High-Risk Patients, Multiple Myeloma Maintenance Therapy: How Long Do I Treat?, and Management of Adverse Events Associated With Maintenance Therapy. 

a
Image Left
White

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.